Published: Mar 21, 2022 Summary: Biocon is a global biopharmaceutical company finding affordable ways to treat diabetes, cancer, and autoimmune diseases. Its businesses include Generics, Biosimilars, Research Services, and Novel Biologics. It has 13,500+ employees. Biocon Biologics, a subsidiary of Biocon, develops high-quality affordable biosimilars. Biocon Biologics buys Viatris biosimilars assets for $3.33 billion. Viatris Continue reading